Medicare Enrolled

Dr. Amarilis Torres, MD

Rheumatology · Zephyrhills, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
38135 MARKET SQ STE 105, Zephyrhills, FL 33542
8137151934
Registered in NPPES since 2006
NPI: 1003927500 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Torres from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Torres? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Torres

Dr. Amarilis Torres is a rheumatology specialist in Zephyrhills, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Torres performed 203,860 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Torres received a total of $21,548 from 42 pharmaceutical and/or device companies across 1239 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Torres is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 9% volume in FL $21,548 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 60985 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
203,860
Medicare services
Top 9% in FL for rheumatology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
75,200 $4 $20
Tocilizumab injection (Actemra) 60,191 $5 $12
Romosozumab injection (Evenity) for osteoporosis 26,250 $8 $23
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
16,210 $26 $180
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
12,150 $11 $56
Denosumab injection (Prolia/Xgeva) 5,820 $18 $47
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
3,925 $34 $131
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
642 $11 $41
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
619 $8 $19
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
482 $66 $186
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
358 $99 $345
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
313 $85 $273
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
271 $0 $1
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
269 $22 $75
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
228 $55 $195
Injection, methylprednisolone acetate, 40 mg 163 $6 $16
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
128 $49 $176
Orthovisc intra-articular injection
An injection of hyaluronan or its derivative into a joint space to provide lubrication and cushioning.
128 $98 $462
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
102 $126 $366
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
99 $60 $232
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
91 $36 $99
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
85 $6 $157
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
42 $30 $74
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
36 $72 $184
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
36 $9 $31
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
22 $18 $56
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
16.1% high complexity
83.1% medium
0.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$21,548
Total received (2018-2024)
Avg $3,078/year across 7 years
Top 21% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
1,239
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,991
2023
$3,416
2022
$3,153
2021
$3,079
2020
$2,505
2019
$2,829
2018
$3,575

Payments by company (2024)

ABBVIE INC.
$572
UCB, Inc.
$382
GENZYME CORPORATION
$341
Janssen Biotech, Inc.
$317
PFIZER INC.
$281
GlaxoSmithKline, LLC.
$221
Novartis Pharmaceuticals Corporation
$207
Fresenius Kabi USA, LLC
$149
Amgen Inc.
$99
Organon Llc
$91
ANI Pharmaceuticals, Inc.
$63
Mallinckrodt Hospital Products Inc.
$54
Kiniksa Pharmaceuticals International, plc
$51
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
SOBI, INC
$37
Radius Health, Inc.
$23
Aurinia Pharma U.S., Inc.
$21
Genentech USA, Inc.
$19
Sandoz Inc.
$17
Top 3 companies account for 43.3% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$2,448
Novartis Pharmaceuticals Corporation
$2,294
AbbVie Inc.
$2,103
Amgen Inc.
$2,052
PFIZER INC.
$1,971
ABBVIE INC.
$1,573
Genentech USA, Inc.
$1,539
GENZYME CORPORATION
$1,318
Janssen Biotech, Inc.
$1,058
AbbVie, Inc.
$937
GlaxoSmithKline, LLC.
$624
Lilly USA, LLC
$515
Radius Health, Inc.
$507
E.R. Squibb & Sons, L.L.C.
$505
Fresenius Kabi USA, LLC
$467
Mallinckrodt Hospital Products Inc.
$318
ANI Pharmaceuticals, Inc.
$155
SOBI, INC
$134
Boehringer Ingelheim Pharmaceuticals, Inc.
$124
Sobi, Inc
$113
Organon Llc
$91
Mallinckrodt Enterprises LLC
$88
Mallinckrodt LLC
$80
Horizon Therapeutics plc
$73
SANOFI-AVENTIS U.S. LLC
$60
Kiniksa Pharmaceuticals International, plc
$51
Daiichi Sankyo Inc.
$44
AstraZeneca Pharmaceuticals LP
$40
Exeltis, USA Inc.
$40
Aurinia Pharma U.S., Inc.
$33
Actelion Pharmaceuticals US, Inc.
$25
Ultragenyx Pharmaceutical Inc.
$25
Organon LLC
$19
Sandoz Inc.
$17
Regeneron Healthcare Solutions, Inc.
$17
IBSA Pharma Inc.
$15
Horizon Pharma plc
$13
FIDIA PHARMA USA INC.
$13
Purdue Pharma L.P.
$13
Kowa Pharmaceuticals America, Inc.
$12
Bioventus LLC
$12
MEDEXUS PHARMA, INC.
$11
Top 3 companies account for 31.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CRYSVITA · CYLTEZO · Cimzia · DUPIXENT DUPILUMAB INJECTION · EVENITY · Enbrel · FORTEO · GELSYN 3 · HUMIRA · HYRIMOZ · Humira · Hymovis · IDACIO · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Licart · Morphabond ER · OFEV · OPSUMIT · ORENCIA · Otezla · PURIFIED CORTROPHIN GEL · Prolia · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SYMPROIC · Seglentis · TALTZ · TREMFYA · Tavneos · Tyenne · Tymlos · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Zephyrhills?
Compare rheumatologists in the Zephyrhills area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
33
County median income
$67,384
Nearest hospital to ZIP centroid (approximate)
Adventhealth Zephyrhills
2.7 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Torres is a mixed practice specialist, with above-average Medicare volume (top 9% in FL), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Torres experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Torres performed 75,200 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Torres receive payments from pharmaceutical companies?
Yes. Dr. Torres received a total of $21,548 from 42 companies across 1,239 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Torres's costs compare to other rheumatologists in Zephyrhills?
Dr. Torres's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Torres) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →